URGN
UroGen Pharma·NASDAQ
--
--(--)
--
--(--)
Latest data update time: Updated on 2026-01-31
Latest data update time: Updated on 2026-01-31
6.25 / 10Overall Score
OutperformInvestment Rating
6.25 / 10Overall Score
OutperformInvestment Rating
Should I Buy URGN Now?
- Based on a composite score of 6.25/10, we rate URGN as a Outperform. Our analysis breaks down into 3.02/10 for Fundamentals, 8.13/10 for Technicals, and 6.94/10 for Sentiment, indicating the stock is likely to See further upside.
What is the current technical signals for URGN?
Is URGN fundamentally strong?
What is the market sentiment for URGN?
Should I Buy URGN Now?
- Based on a composite score of 6.25/10, we rate URGN as a Outperform. Our analysis breaks down into 3.02/10 for Fundamentals, 8.13/10 for Technicals, and 6.94/10 for Sentiment, indicating the stock is likely to See further upside.
Is URGN fundamentally strong?
What is the current technical signals for URGN?
What is the market sentiment for URGN?
